T2C2 Capital

What's included with your PrivCo Premium Subscription:

FULL REPORTS: Instant online access to 209,399+ private company reports, with more being added daily!
PDF DOWNLOADS: Download Company Reports in PDF Format (View Sample Company Report in PDF Format)
EXCEL EXPORTS: Export Company Data to Excel! (View Sample Company Report in Excel)
ADVANCED FINANCIAL SEARCH: Revenue, Employee Count, Growth Rate/CAGR, Industry, Specialty Tags and more, plus Excel Export! (View Company Advanced Search)

VC FUNDING DEALS: Full access to 36,245+ Funding Deals, including breakdowns, terms, and analysis. (View Sample VC Funding Deal, View VC Funding Search)
PRIVATE M&A DEALS: Full access to 43,309+ M&A and Private Equity Deals, including deal multiples, deal advisors, and more. (View Sample M&A Deal, View M&A Deal Search)
INVESTOR RECORDS AND EMAILS: Full access to 12,095+ Investor Profiles, including PE Firms, VC Firms, Angel Groups, & more with PARTNER & EXEC. NAMES AND DIRECT EMAILS! (View Sample Investor Report)

Investor Overview

Preferred Stage:

Seed
Early Stage
Mid Stage / Expansion

Investor Contacts

Below are direct e-mail contacts for senior professionals at T2C2 Capital.

Full contact details are available with a PrivCo Premium Subscription.

Instant Full Site-Wide Access
Currently 50% Off Until May. 31!

Name	Title	E-mail
Bertrand Cayrol	VP (BIO)	E-mail Bertrand Cayrol Directly
Bernard Coupal	President	E-mail Bernard Coupal Directly
Chantal Lachapelle	Controller	E-mail Chantal Lachapelle Directly

Private Deal History

This table is intended to portray T2C2 Capital PrivCo-covered market activity. Click below for Deal Details and Private Company Reports.

All data before 2006 is completely free to view! To access data from 2006 onward:

Instant Full Site-Wide Access
Currently 50% Off Until May. 31!

Date	Target	Target Industry	Deal Type	Total Deal Amount	Status
Jul. 2008	View	Pharmaceutical & Drug Manufacturing Pharmaceutical Research & Drug Discovery	Funding	View	Completed	Details
Jul. 2006	View	Biotechnology	Funding	View	Completed	Details
May. 2005	BioAxone Therapeutic	Biotechnology	Funding	$12,200,000	Completed	Details
Dec. 2001	Cytochroma Inc.	Pharmaceutical & Drug Manufacturing Pharmaceutical Research & Drug Discovery	Funding	C$3,500,000 [CAD]	Completed	Details

Choose Region(s):
Or Enter Location (US, CAN, UK): within miles
Investor Type:
Go to Advanced Search

Investor Summary